Faeth Therapeutics (FTH) EPS (Basic) (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly EPS (Basic) came in at -$131.45 in Q1 2026, down 48145.39% YoY from N/an in Q1 2025, and down 3413.46% on a QoQ basis from -$3.74 in Q4 2025.
Faeth Therapeutics (FTH) EPS (Basic) (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of EPS (Basic) data on file, last reported at -$131.45 in Q1 2026.
- Quarterly EPS (Basic) fell 48145.39% year-over-year to -$131.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$142.43 (down 12260.82% YoY) and the FY2025 annual result came in at -$16.72, down 1292.9% from the prior year.
- EPS (Basic) declined to -$131.45 in Q1 2026, from -$3.74 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.27 in Q4 2023 to a low of -$131.45 in Q1 2026.
- A 5-year average of -$8.65 and a median of -$0.33 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 36.06% — and 2026, when it plunged 48145.39%.
- Tracing FTH's EPS (Basic) over 5 years: stood at -$0.4 in 2022, then surged by 33.42% to -$0.27 in 2023, then slipped by 16.63% to -$0.31 in 2024, then tumbled by 1109.43% to -$3.74 in 2025, then sank by 3413.46% to -$131.45 in 2026.
- The last three EPS (Basic) figures came in at -$131.45 (Q1 2026), -$3.74 (Q4 2025), and -$3.62 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | -2.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.84 |
| Mar 31, 2026 | -131.45 |
| Dec 31, 2025 | -3.74 |
| Sep 30, 2025 | -3.62 |
| Jun 30, 2025 | -3.91 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.31 |
| Sep 30, 2024 | -0.29 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.28 |
| Jun 30, 2023 | -0.31 |
| Mar 31, 2023 | -0.33 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.34 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.32 |